AIP
GSK icon

Ahrens Investment Partners’s GSK GSK Stock Holding History

Ahrens Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$95.6K Buy
+2,687
New +$94K 0.05% 223
2022
Q3 		– Sell
-2,895
Closed -$158K – 473
2022
Q2 		$158K Buy
2,895
+48
+2% +$2.65K 0.07% 179
2022
Q1 		$155K Buy
2,847
+400
+16% +$21.7K 0.05% 212
2021
Q4 		$135K Buy
+2,447
New +$127K 0.06% 243

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ahrens Investment Partners's GSK Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in GSK (GSK) in Q1 2023: 2,687 shares worth $95.6K. The stake represents 0.05% of the portfolio and ranks #223 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in GSK as recently as Q2 2022.

Ahrens Investment Partners first reported a position in GSK in Q4 2021 and has held it in 4 quarters since. The position peaked at $158K in Q2 2022. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • Ahrens Investment Partners held 2,687 shares of GSK worth $95.6K as of Q1 2023.
  • GSK was a new Ahrens Investment Partners position in Q1 2023.
  • GSK made up 0.05% of Ahrens Investment Partners's portfolio in Q1 2023, its #223 holding.
  • Ahrens Investment Partners first reported a position in GSK in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's GSK position peaked at $158K in Q2 2022.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.